Clinical performance of a specific algorithm to reconfirm self-terminating ventricular arrhythmias in current implantable cardioverter-defibrillators

2001 ◽  
Vol 88 (7) ◽  
pp. 744-749 ◽  
Author(s):  
Tanja M Raedle-Hurst ◽  
Johannes Wiecha ◽  
Joerg O Schwab ◽  
Heiko Schmitt ◽  
Michael Hinrichs ◽  
...  
Keyword(s):  
Ventricular Arrhythmias ◽  
Clinical Performance ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

Psychosocial Issues of Patients With Implantable Cardioverter Defibrillators

2005 ◽  
Vol 14 (4) ◽  
pp. 294-303 ◽  
Author(s):  
Sandra B. Dunbar
Keyword(s):  
Quality Of Life ◽  
High Risk ◽  
Standard Therapy ◽  
Ventricular Arrhythmias ◽  
Evidence Based ◽  
Psychosocial Issues ◽  
Implantable Cardioverter Defibrillators ◽  
Life Threatening ◽  
Cardioverter Defibrillators

Use of implantable cardioverter defibrillators has become standard therapy for patients at high risk for life-threatening ventricular arrhythmias. Although acceptance of the device is generally high among patients and their families, quality of life and psychosocial issues associated with use of the defibrillators deserve greater attention to improve outcomes. Psychosocial issues, their ramifications, and theory-and evidence-based approaches to improving outcomes are described.

scholarly journals P-312 False negative detections of ventricular arrhythmias registered by holter memory of implantable cardioverter-defibrillators

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_2) ◽  
pp. B139-B140
Author(s):  
T. Krolak ◽  
A. Lubinski ◽  
M. Kempa ◽  
E. Lewicka-Nowak ◽  
A. Pazdyga ◽  
...  
Keyword(s):  
Ventricular Arrhythmias ◽  
False Negative ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

scholarly journals Usefulness of Left Atrial Emptying Fraction to Predict Ventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillators

2017 ◽  
Vol 120 (2) ◽  
pp. 243-250 ◽  
Author(s):  
Mischa T. Rijnierse ◽  
Mehran Kamali Sadeghian ◽  
Sophie Schuurmans Stekhoven ◽  
P. Stefan Biesbroek ◽  
Anne-Lotte C. van der Lingen ◽  
...  
Keyword(s):  
Left Atrial ◽  
Ventricular Arrhythmias ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

Ventricular Arrhythmias: Antiadrenergic Therapy for the Patient with Coronary Artery Disease

2005 ◽  
Vol 10 (4_suppl) ◽  
pp. S23-S31 ◽  
Author(s):  
Stefan H. Hohnloser
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Ventricular Arrhythmias ◽  
Clinical Evidence ◽  
Synergistic Effects ◽  
Implantable Cardioverter Defibrillators ◽  
Patients At Risk ◽  
Adrenergic Blockers ◽  
Artery Disease ◽  
Cardioverter Defibrillators

Patients who have had a recent myocardial infarction (MI) are at high risk of ventricular arrhythmias that often cause sudden cardiac death. It is believed that sympathetic overactivity in the peri-infarction period may alter the electrophysiology and structure of the myocardium, thus placing these patients at risk of developing rhythm disturbances. A number of pharmacologic and nonpharmacologic therapies have been shown to reduce the risk of post-MI mortality, including sudden cardiac death. β-Adrenergic blockers are recommended for all post-MI patients without contraindications because of overwhelming clinical evidence of their benefit in reducing mortality in this patient population. Recent clinical trials of implantable cardioverter defibrillators have provided compelling support that they are effective in both the primary and secondary prevention of sudden cardiac death. In addition, several studies have shown that combination therapy with β-blockers and implantable cardioverter defibrillators have synergistic effects that optimize the benefits of both therapies.

Sign in / Sign up

Export Citation Format

Share Document